Effect of Russian Current Stimulation for Anterior Tibial Group on Postural Stability and Risk of Falling in Patients With Stroke
Launched by CAIRO UNIVERSITY · Jan 21, 2025
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Russian current stimulation to see how it affects balance and the risk of falling in patients who have had a stroke. The focus is on a specific muscle group in the lower leg called the anterior tibial group, which is important for walking and stability. The researchers hope that this treatment will help improve postural stability, making it safer for patients to move around.
To be part of this study, participants need to be between 40 and 55 years old and have had a stroke that caused weakness in the anterior tibial muscles. They should also have moderate muscle tightness, and their body weight should be within a certain range. However, individuals with severe muscle tightness, certain heart conditions, infections, or emotional and cognitive issues won't be eligible. If you participate, you can expect to receive the stimulation treatment and be monitored for its effects on your balance and fall risk. This study is currently looking for volunteers to join.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Forty patient with stroke manifest with weakness of anterior tibial group.
- • Patients with moderate spasticity,
- • Patient's ages ranged from 40-55 years.
- • Patients BMI not exceed 30 kg/m².
- • Medically and clinically stable patients.
- Exclusion Criteria:
- • Patients suffering from psychological, cognitive, or emotional disturbance.
- • Patients with severe spasticity (3 or more by the modified Ashworth scale).
- • Patients with atrial fibrillation.
- • Patients with infectious processes.
- • Patients with impaired pain sensitivity.
- • Patients with epilepsy.
- • Patients with lower limb joint endoprosthetics.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minya, , Egypt
Patients applied
Trial Officials
Hoda Mohamed Zakaria, PhD
Study Chair
Professor, Cairo University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported